<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35108352</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>09</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1938-3207</ISSN><JournalIssue CitedMedium="Internet"><Volume>115</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>May</Month><Day>01</Day></PubDate></JournalIssue><Title>The American journal of clinical nutrition</Title><ISOAbbreviation>Am J Clin Nutr</ISOAbbreviation></Journal><ArticleTitle>Body composition in amyotrophic lateral sclerosis subjects and its effect on disease progression and survival.</ArticleTitle><Pagination><StartPage>1378</StartPage><EndPage>1392</EndPage><MedlinePgn>1378-1392</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/ajcn/nqac016</ELocationID><Abstract><AbstractText Label="BACKGROUND">Motor neuron degeneration and malnutrition alter body composition in amyotrophic lateral sclerosis (ALS). Resulting losses of weight, fat mass (FM), and fat-free mass (FFM) shorten survival. Nutritional management relies on body weight or BMI; neither reliably indicates malnutrition nor differentiates body compartments.</AbstractText><AbstractText Label="OBJECTIVES">We aimed to 1) develop an equation to compute FM and FFM using clinical data, validated against DXA; and 2) examine the effect of computed FM and FFM on disease course and survival.</AbstractText><AbstractText Label="METHODS">We studied 364 ALS patients from 3 cohorts. In Cohort #1 we used logistic regression on clinical and demographic data to create an equation (test cohort). In Cohort #2 we validated FM and FFM computed using this equation against DXA (validation cohort). In Cohort #3, we examined the effect of computed body composition on disease course and survival.</AbstractText><AbstractText Label="RESULTS">In Cohort #1 (n&#xa0;=&#xa0;29) the model incorporated sex, age, BMI, and bulbar-onset to create an equation to estimate body fat: % body fat&#xa0;=&#xa0;1.73 - [19.80*gender (1 if male or 0 if female)] + [0.25*weight (kg)] + [0.95*BMI (kg/m2)] - (5.20*1 if bulbar-onset or *0 if limb-onset). In Cohort #2 (n&#xa0;=&#xa0;104), body composition using this equation, compared to other published equations, showed the least variance from DXA values. In Cohort #3 (n&#xa0;=&#xa0;314), loss of body composition over 6 mo was greater in males. Adjusted survival was predicted by low baseline FM (HR: 1.39; 95% CI: 1.07, 1.80), and loss of FM (HR: 1.87; 95% CI: 1.30, 2.69) and FFM (HR: 1.73; 95% CI: 1.20, 2.49) over 6 mo.</AbstractText><AbstractText Label="CONCLUSIONS">Our equation broadens the traditional nutritional evaluation in clinics and reliably estimates body composition. Measuring body composition could target FM as a focus for nutritional management to ensure adequate energy intake and complement measures, such as the ALS functional rating scale-revised score and forced vital capacity, currently used.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2022. Published by Oxford University Press on behalf of the American Society for Nutrition.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tandan</LastName><ForeName>Rup</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurological Sciences, University of Vermont Medical Center and Robert Larner, MD College of Medicine, University of Vermont, Burlington, VT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>General Clinical Research Center, University of Vermont Medical Center and Robert Larner, MD College of Medicine, University of Vermont, Burlington, VT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levy</LastName><ForeName>Evan A</ForeName><Initials>EA</Initials><AffiliationInfo><Affiliation>Department of Neurological Sciences, University of Vermont Medical Center and Robert Larner, MD College of Medicine, University of Vermont, Burlington, VT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>General Clinical Research Center, University of Vermont Medical Center and Robert Larner, MD College of Medicine, University of Vermont, Burlington, VT, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Howard</LastName><ForeName>Diantha B</ForeName><Initials>DB</Initials><AffiliationInfo><Affiliation>General Clinical Research Center, University of Vermont Medical Center and Robert Larner, MD College of Medicine, University of Vermont, Burlington, VT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Northern New England Clinical and Translational Research Network, Robert Larner, MD College of Medicine, University of Vermont, Burlington, VT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Maine Medical Center Research Institute, Portland, ME, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hiser</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>General Clinical Research Center, University of Vermont Medical Center and Robert Larner, MD College of Medicine, University of Vermont, Burlington, VT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Northern New England Clinical and Translational Research Network, Robert Larner, MD College of Medicine, University of Vermont, Burlington, VT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Maine Medical Center Research Institute, Portland, ME, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kokinda</LastName><ForeName>Nathan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>General Clinical Research Center, University of Vermont Medical Center and Robert Larner, MD College of Medicine, University of Vermont, Burlington, VT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Northern New England Clinical and Translational Research Network, Robert Larner, MD College of Medicine, University of Vermont, Burlington, VT, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Maine Medical Center Research Institute, Portland, ME, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dey</LastName><ForeName>Swatee</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Kentucky, Lexington, KY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>General Clinical Research Center, University of Kentucky, Lexington, KY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kasarskis</LastName><ForeName>Edward J</ForeName><Initials>EJ</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Kentucky, Lexington, KY, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>General Clinical Research Center, University of Kentucky, Lexington, KY, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Am J Clin Nutr</MedlineTA><NlmUniqueID>0376027</NlmUniqueID><ISSNLinking>0002-9165</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015502" MajorTopicYN="N">Absorptiometry, Photon</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001823" MajorTopicYN="N">Body Composition</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015992" MajorTopicYN="N">Body Mass Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017097" MajorTopicYN="N">Electric Impedance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044342" MajorTopicYN="Y">Malnutrition</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">body composition</Keyword><Keyword MajorTopicYN="N">body mass index</Keyword><Keyword MajorTopicYN="N">disease progression</Keyword><Keyword MajorTopicYN="N">dual energy X-ray absorptiometry</Keyword><Keyword MajorTopicYN="N">fat mass</Keyword><Keyword MajorTopicYN="N">fat-free mass</Keyword><Keyword MajorTopicYN="N">nutrition</Keyword><Keyword MajorTopicYN="N">survival</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>2</Day><Hour>17</Hour><Minute>15</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35108352</ArticleId><ArticleId IdType="pmc">PMC9071423</ArticleId><ArticleId IdType="doi">10.1093/ajcn/nqac016</ArticleId><ArticleId IdType="pii">S0002-9165(22)00260-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, Shaw PJ, Simmons Z, van&#xa0;den&#xa0;Berg LH. Amyotrophic lateral sclerosis. Nat Rev Dis Primers. 2017;3:17071.</Citation><ArticleIdList><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Desport JC, Preux PM, Truong TC, Vallat JM, Sauterau D, Couratier P. Nutritional status is a prognostic factor for survival in ALS patients. Neurology. 1999;53(5):1059&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">10496266</ArticleId></ArticleIdList></Reference><Reference><Citation>Genton L, Viatte V, Janssens JP, H&#xe9;ritier AC, Pichard C. Nutritional state, energy intakes and energy expenditure of amyotrophic lateral sclerosis (ALS). Clin Nutr. 2011;30(5):553&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">21798636</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasarskis EJ, Berryman S, Vanderleest JG, Schneider AR, McClain CJ. Nutritional status of patients with amyotrophic lateral sclerosis: relation to the proximity of death. Am J Clin Nutr. 1996;63(1):130&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">8604660</ArticleId></ArticleIdList></Reference><Reference><Citation>Nau KL, Dick AR, Peters K, Schloerb PR. Relative validity of clinical techniques for measuring the body composition of persons with ALS. J Neurol Sci. 1997;152(1):s36&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">9419052</ArticleId></ArticleIdList></Reference><Reference><Citation>Moglia C, Calvo A, Grassano M, Canosa A, Manera U, D'Ovidio F, Bombaci A, Bersano E, Mazzini L, Mora Get al. . Early weight loss in amyotrophic lateral sclerosis: outcome relevance and clinical correlates in a population-based cohort. J Neurol Neurosurg Psychiatry. 2019;90(6):666&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">30630957</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin B, Desport JC, Kajeu P, Jesus P, Nicolaud B, Nicol M, Preux PM, Couratier P. Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients. J Neurol Neurosurg Psychiatry. 2011;82(6):628&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">21097551</ArticleId></ArticleIdList></Reference><Reference><Citation>Cereda E, Veronese N, Caccialanza R. The final word on nutritional screening and assessment in older persons. Curr Opin Clin Nutr Metab Care. 2018;21(1):24&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">29035968</ArticleId></ArticleIdList></Reference><Reference><Citation>Worwood AM, Leigh PN. Indicators and prevalence of malnutrition in motor neurone disease. Eur Neurol. 1998;40(3):159&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pubmed">9748674</ArticleId></ArticleIdList></Reference><Reference><Citation>Roubeau V, Blasco H, Maillot F, Corcia P, Praline J. Nutritional assessment of amyotrophic lateral sclerosis in routine practice: value of weighing and bioelectrical impedance analysis. Muscle Nerve. 2015;51(4):479&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">25130859</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannides ZA, Steyn FJ, Henderson RD, Mccombe PA, Ngo ST. Anthropometric measures are not accurate predictors of fat mass in ALS. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18(7&#x2013;8):486&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">28446030</ArticleId></ArticleIdList></Reference><Reference><Citation>Jensen MD, Kanaley JA, Roust LR, O'Brien PC, Braun JS, Dunn WL, Wahner HW. Assessment of body composition with use of dual-energy x-ray absorptiometry: evaluation and comparison with other methods. Mayo Clin Proc. 1993;68(9):867&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">8371605</ArticleId></ArticleIdList></Reference><Reference><Citation>Wellens R, Chumlea WC, Guo S, Roche AF, Reo NV, Siervogel RM. Body composition in white adults by dual energy x-ray absorptiometry, densitometry, and total body water. Am J Clin Nutr. 1994;59(3):547&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">8116529</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith S, Madden AS. Body composition and functional assessment of nutritional status in adults: a narrative review of imaging, impedance, strength and functional techniques. J Hum Nutr Diet. 2016;29(6):714&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">27137882</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasarskis EJ, Berryman S, English T, Nyland J, Vanderleest J, Schneider A, Berger R, McClain C. The use of upper extremity anthropometrics in the clinical assessment of patients with amyotrophic lateral sclerosis. Muscle Nerve. 1997;20(3):330&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">9052812</ArticleId></ArticleIdList></Reference><Reference><Citation>Geisler C, Braun W, Pourhassan M, Schweitzer L, Gl&#xfc;er C-C, Bosy-Westphal A, M&#xfc;ller MJ. Gender-specific associations in age-related changes in resting energy expenditure (REE) and MRI measured body composition in healthy Caucasians. J Gerontol A Biol Sci Med Sci. 2016;71(7):941&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">26590912</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL, World Federation of Neurology Research Group on Motor Neuron Diseases . El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1(5):293&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Traynor BJ, Zhang H, Shefner JM, Schoenfeld D, Cudkowicz ME, NEALS consortium . Functional outcome measures as clinical trial endpoints in ALS. Neurology. 2004;63(10):1933&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">15557515</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasarskis EJ, Mendiondo M, Wells S, Malguizo MS, Thompson M, Healey M, Kryscio RJ, ALS Nutrition/NIPPV Study Group . The ALS Nutrition/NIPPV study: design, feasibility, and initial results. Amyotroph Lateral Scler. 2011;12(1):17&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">21271789</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasarskis EJ, Mendiondo MS, Matthews DE, Mitsumoto H, Tandan R, Simmons Z, Bromberg MB, Kryscio RJ, ALS Nutrition/NIPPV Study Group . Estimating daily energy expenditure in individuals with amyotrophic lateral sclerosis. Am J Clin Nutr. 2014;99(4):792&#x2013;803.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3953880</ArticleId><ArticleId IdType="pubmed">24522445</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson AS, Pollock ML, Ward A. Generalized equations for predicting body density of women. Med Sci Sports Exerc. 1980;12(3):175&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">7402053</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson AS, Pollock ML. Generalized equations for predicting body density of men. 1978. Br J Nutr. 2004;91(1):161&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">14748950</ArticleId></ArticleIdList></Reference><Reference><Citation>Durnin JV, Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr. 1974;32(1):77&#x2013;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">4843734</ArticleId></ArticleIdList></Reference><Reference><Citation>Deurenberg P, Westrate JA, Seidell JC. Body mass index as a measure of body fatness: age- and sex-specific prediction formulas. Br J Nutr. 1991;65(2):105&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">2043597</ArticleId></ArticleIdList></Reference><Reference><Citation>Rehs HJ, Berndt I, Rutenfranz J, Burmeister W. [Determination of lean body mass by skin fold measurements (author's translation)]. Z Kinderheilkd. 1975;120(2):121&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">1163076</ArticleId></ArticleIdList></Reference><Reference><Citation>Haarbo J, Gotfredsen A, Hassager C, Christiansen C. Validation of body composition by dual energy X-ray absorptiometry. Clin Physiol. 1991;11(4):331&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">1914437</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanda F, Fujii Y, Takahashi K, Fujita T. Dual-energy X-ray absorptiometry in neuromuscular diseases. Muscle Nerve. 1994;17(4):431&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">8170490</ArticleId></ArticleIdList></Reference><Reference><Citation>Nau KL, Bromberg MB, Forshew DA, Katch VL. Individuals with amyotrophic lateral sclerosis are in caloric balance despite losses in mass. J Neurol Sci. 1995;129:47&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">7595619</ArticleId></ArticleIdList></Reference><Reference><Citation>Desport JC, Preux PM, Bouteloup-Demange C, Clavelou P, Beaufr&#x450;re B, Bonnet C, Couratier PP. Validation of bioelectrical impedance analysis in patients with amyotrophic lateral sclerosis. Am J Clin Nutr. 2003;77(5):1179&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pubmed">12716669</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouteloup C, Desport J-C, Clavelou P, Guy N, Derumeaux-Burel H, Ferrier A, Couratier P. Hypermetabolism in ALS patients: an early and persistent phenomenon. J Neurol. 2009;256(8):1236&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">19306035</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaisman N, Lusaus M, Nefussy B, Niv E, Comaneshter D, Hallack R, Drory VE. Do patients with amyotrophic lateral sclerosis (ALS) have increased energy needs?. J Neurol Sci. 2009;279(1&#x2013;2):26&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">19185883</ArticleId></ArticleIdList></Reference><Reference><Citation>Giavarina D. Understanding Bland Altman analysis. Biochem Med (Zagreb). 2015;25(2):141&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4470095</ArticleId><ArticleId IdType="pubmed">26110027</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganoni S, Deng J, Jaffa M, Cudkowicz ME, Wills AM. Body mass index, not dyslipidemia, is an independent predictor of survival in amyotrophic lateral sclerosis. Muscle Nerve. 2011;44(1):20&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4441750</ArticleId><ArticleId IdType="pubmed">21607987</ArticleId></ArticleIdList></Reference><Reference><Citation>Reich-Slotky R, Andrews J, Cheng B, Buchsbaum R, Levy D, Kaufmann P, Thompson JLP. Body mass index (BMI) as a predictor of ALSFRS-R score decline in ALS patients. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14(3):212&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">23452274</ArticleId></ArticleIdList></Reference><Reference><Citation>Atassi N, Berry J, Shui A, Zach N, Sherman A, Sinani E, Walker J, Katsovskiy I, Schoenfeld D, Cudkowicz Met al. . The PRO-ACT database: design, initial analyses, and predictive features. Neurology. 2014;83(19):1719&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4239834</ArticleId><ArticleId IdType="pubmed">25298304</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzini L, Corr&#xe0; T, Zaccala M, Mora G, Del&#xa0;Piano M, Galante M. Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis. J Neurol. 1995;242(10):695&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">8568533</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez&#xa0;G&#xf3;mez JJ, Ballesteros&#xa0;Pomar MD, V&#xe1;zquez&#xa0;S&#xe1;nchez F, Vidal&#xa0;Casariego A, Calleja&#xa0;Fern&#xe1;ndez A, Cano&#xa0;Rodr&#xed;guez I. [Effect of nutritional support on survival in patients with amyotrophic lateral sclerosis]. Nutr Hosp. 2011;26(3):515&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">21892569</ArticleId></ArticleIdList></Reference><Reference><Citation>Dorst J, Cypionka J, Ludolph AC. High-caloric food supplements in the treatment of amyotrophic lateral sclerosis: a prospective interventional study. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14(7&#x2013;8):533&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">23944684</ArticleId></ArticleIdList></Reference><Reference><Citation>Wills AM, Hubbard J, Macklin EA, Glass J, Tandan R, Simpson EP, Brooks B, Gelinas D, Mitsumoto H, Mozaffar Tet al. . Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled phase 2 trial. Lancet. 2014;383(9934):2065&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4176708</ArticleId><ArticleId IdType="pubmed">24582471</ArticleId></ArticleIdList></Reference><Reference><Citation>Keys A, Bro&#x17e;ek J, Henschel A, Mickelsen O, Taylor HL, Simonson E, Skinner AS, Wells SM, editors, with the assistance of. The biology of human starvation. Vols I and II. Minneapolis, MN: University of Minnesota Press; 1950.</Citation></Reference><Reference><Citation>Ludolph AC, Dorst J, Dreyhaupt J, Weishaupt JH, Kassubek J, Weiland U, Meyer T, Petri S, Hermann A, Emmer Aet al. . Effect of high-caloric nutrition on survival in amyotrophic lateral sclerosis. Ann Neurol. 2020;87(2):206&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">31849093</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindauer E, Dupuis L, M&#xfc;ller HP, Neumann H, Ludolph AC, Kassubek J. Adipose tissue distribution predicts survival in amyotrophic lateral sclerosis. PLoS One. 2013;8(6):e677&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3694869</ArticleId><ArticleId IdType="pubmed">23826340</ArticleId></ArticleIdList></Reference><Reference><Citation>J&#xe9;sus P, Fayemendy P, Nicol M, Lautrette G, Sourisseau H, Preux P-M, Desport J-C, Marin B, Couratier P. Hypermetabolism is a deleterious prognostic factor in patients with amyotrophic lateral sclerosis. Eur J Neurol. 2018;25(1):97&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pubmed">28940704</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee I, Kazamel M, McPherson T, McAdam J, Bamman M, Amara A, Smith DL, King PH. Fat mass loss correlates with faster disease progression in amyotrophic lateral sclerosis patients: exploring the utility of dual-energy x-ray absorptiometry in a prospective study. PLoS One. 2021;16(5):e0251087.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8101939</ArticleId><ArticleId IdType="pubmed">33956876</ArticleId></ArticleIdList></Reference><Reference><Citation>Fasshauer M, Bluher M. Adipokines in health and disease. Trends Pharmacol Sci. 2015;36(7):461&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">26022934</ArticleId></ArticleIdList></Reference><Reference><Citation>Hellstr&#xf6;m L, Wahrenberg H, Hruska K, Reynisdottir S, Arner P. Mechanisms behind gender differences in circulating leptin levels. J Intern Med. 2000;247(4):457&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">10792559</ArticleId></ArticleIdList></Reference><Reference><Citation>Blaak E. Gender differences in fat metabolism. Curr Opin Clin Nutr Metab Care. 2001;4(6):499&#x2013;502.</Citation><ArticleIdList><ArticleId IdType="pubmed">11706283</ArticleId></ArticleIdList></Reference><Reference><Citation>Tandan R, Waheed W, Scagnelli C. Nutritional consequences of amyotrophic lateral sclerosis. In: Preedy VR, Patel VB, editors. Handbook of famine, starvation, and nutrient deprivation: from biology to policy. London, United Kingdom: Springer; 2019. Chapter 108.</Citation></Reference><Reference><Citation>Park Y, Park J, Kim Y, Baek H, Kim SH. Association between nutritional status and disease severity using the amyotrophic lateral sclerosis (ALS) functional rating scale in ALS patients. Nutrition. 2015;31(11&#x2013;12):1362&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">26429656</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>